Regulatory Framework in Clinical Trials

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Regulatory Framework in Clinical Trials in Colombia

Regulatory Framework in Clinical Trials in Colombia – Cohortias the CRO of LATAM

Clinical trials play a vital role in advancing medical research and bringing new treatments to patients. To ensure the safety and efficacy of these trials, a robust regulatory framework is necessary. In Colombia, significant strides have been made in establishing a comprehensive regulatory framework for clinical trials.

This blog post aims to provide an overview of the regulatory framework governing clinical trials in Colombia, highlighting key regulations, ethical considerations, and the approval process.

Regulatory Bodies and Key Legislations:

The National Institute for Food and Drug Surveillance (INVIMA) is the primary regulatory authority responsible for overseeing clinical trials in Colombia. INVIMA is dedicated to safeguarding public health by enforcing regulations and standards for clinical research. Key legislations governing clinical trials in Colombia include:

  1. Resolution 2378 of 2008: This resolution sets forth the guidelines for conducting clinical trials in Colombia. It outlines the requirements for trial authorization, ethics committee review, informed consent, and data management.
  2. Resolution 8430 of 1993: This resolution establishes the ethical principles and guidelines for biomedical research involving human subjects, aligning with international standards such as the Declaration of Helsinki.

Ethical Considerations:

Ethical considerations are paramount in clinical research to protect the rights and welfare of trial participants. Colombian clinical trials adhere to internationally recognized ethical guidelines, ensuring the highest standards of conduct. Key ethical principles include:

  1. Informed Consent: Participants must provide informed consent after receiving comprehensive information about the trial, including potential risks, benefits, and their rights. Informed consent is an ongoing process throughout the trial.
  2. Research Ethics Committees (RECs): Every clinical trial must be reviewed and approved by an REC, which evaluates the scientific and ethical aspects of the trial, ensuring participant protection and compliance with ethical guidelines.
  3. Vulnerable Populations: Additional safeguards are in place to protect vulnerable populations, such as minors, pregnant women, and prisoners. These safeguards include stringent criteria for their inclusion in trials and specific measures to ensure their rights and well-being.

Regulatory Framework in Clinical Trials in Colombia

Regulatory Framework in Clinical Trials in Colombia

Regulatory Framework in Clinical Trials in Colombia

Approval Process:

The approval process for clinical trials in Colombia involves several steps to ensure compliance with regulations and ethical standards. Key stages in the approval process include:

  1. Submission of Clinical Trial Application: Researchers or sponsors submit a detailed application to INVIMA, including the trial protocol, investigator credentials, informed consent documents, and relevant supporting documentation.
  2. Review by INVIMA: INVIMA evaluates the application for scientific and technical validity, patient safety measures, and compliance with regulatory requirements. This review ensures that the trial meets the necessary quality standards.
  3. Ethics Committee Review: Simultaneously, the trial protocol undergoes review by an REC, which assesses the scientific and ethical aspects of the trial. The REC’s approval is required for the trial to proceed.
  4. Approval and Monitoring: Once both INVIMA and the REC grant approval, the trial can commence. INVIMA conducts periodic inspections and monitoring throughout the trial to ensure ongoing compliance with regulations and participant safety.

Post-Approval Responsibilities:

Following approval, researchers and sponsors have certain responsibilities to fulfill during and after the clinical trial. These responsibilities include:

  1. Adverse Event Reporting: Researchers must promptly report any adverse events or safety concerns to INVIMA and the REC, ensuring continuous monitoring of participant safety.
  2. Data Management and Confidentiality: Adequate data collection, management, and confidentiality measures must be in place to ensure the integrity and privacy of trial data.
  3. Trial Conclusion and Reporting: Upon completion of the trial, researchers are required to submit comprehensive final reports to INVIMA, including study results, analysis, and conclusions.


Colombia’s regulatory framework for clinical trials demonstrates a commitment to promoting medical innovation while safeguarding participant safety and ethical conduct.

Regulatory Framework in Clinical Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Regulatory Framework in Clinical Trials

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Regulatory Framework in Clinical Trials

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Regulatory Framework in Clinical Trials

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Regulatory Framework in Clinical Trials

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Regulatory Framework in Clinical Trials

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Regulatory Framework in Clinical Trials

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Regulatory Framework in Clinical Trials

The Cohortias Team

Regulatory Framework in Clinical Trials

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Regulatory Framework in Clinical Trials

Network & Partnerships